Tolebrutinib was found to delay disability progression in people with nonrelapsing secondary progressive MS in a Phase 3 clinical trial.

Background Previous natural history studies highlighted a consistent heterogeneity of disability trajectories among ...

UK researchers have unveiled an innovative artificial intelligence (AI) tool, named MindGlide, designed to interpret and ...

In the wake of Gaikwad's injury, Chennai Super Kings (CSK) have turned to a familiar face - 43-year-old MS Dhoni - to lead ...

A new artificial intelligence (AI) tool called MindGlide was found to accurately calculate MS-related brain damage using a ...

Rangely District Hospital is excited to unveil our brand-new MRI suite, a game-changing addition that underscores our ...

A type of MRI may cause certain metal nanoparticles to form in the body. Experts explain why MRIs with contrast may lead to ...

A new AI tool, MindGlide, can rapidly analyze routine brain MRI scans to detect subtle changes caused by multiple sclerosis ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...

Researchers at UCL have developed an innovative AI tool called MindGlide, designed to transform the way MS treatments are ...

Read more on Blair's MS journey with "Dr. B" in our new April issue — which also features emotional first-person accounts ...

The integration of deep learning in neuroimaging enhances diagnostic capabilities, offering new insights into neurological ...